These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [The use of immunosuppressive drugs in the treatment of rheumatoid arthritis]. Pascual Gómez E Med Clin (Barc); 1983 Oct; 81(12):540-4. PubMed ID: 6656371 [No Abstract] [Full Text] [Related]
24. [Immunosuppressive therapy of secondary amyloidosis associated with rheumatoid arthritis or Still's disease]. Blanche P; Menkès CJ Rev Rhum Mal Osteoartic; 1992 Dec; 59(12):784-9. PubMed ID: 1308968 [TBL] [Abstract][Full Text] [Related]
25. [The comparative characteristics of parlodel, zinc sulfate and recombinant erythropoietin in treating uremic hypogonadism in patients on chronic hemodialysis]. Kukhtevich AV; Ermolenko VM; Dedov II; Gitel' EP; Buniatian AF; Smirnova GA Ter Arkh; 1992; 64(11):66-70. PubMed ID: 1293848 [No Abstract] [Full Text] [Related]
26. [Role of immunosuppressive agents in the treatment of rheumatoid polyarthritis in adults]. Le Loet X; Deshayes P LARC Med; 1983; 3(6):413-5. PubMed ID: 6888107 [No Abstract] [Full Text] [Related]
27. [Rheumatoid arthritis and the kidneys]. Mustonen J; Helin H; Korpela M; Pasternack A Duodecim; 1985; 101(16):1549-56. PubMed ID: 4054012 [No Abstract] [Full Text] [Related]
28. High-dose immunosuppressive therapy for rheumatoid arthritis: some answers, more questions. McSweeney PA; Furst DE; West SG Arthritis Rheum; 1999 Nov; 42(11):2269-74. PubMed ID: 10555019 [No Abstract] [Full Text] [Related]
29. [Immediate and remote results of immunosuppressive therapy of rheumatoid arthritis in children]. Dolgopolova AV; Melikhova NI; Peterson IS; Kostrova AA Vopr Revm; 1975; (2):43-6. PubMed ID: 1189379 [No Abstract] [Full Text] [Related]
30. Lymphomatoid granulomatosis in a patient with rheumatoid arthritis receiving methotrexate: successful treatment with the anti-CD20 antibody mabthera. Schalk E; Krogel C; Scheinpflug K; Mohren M Onkologie; 2009 Jul; 32(7):440-1. PubMed ID: 19556825 [No Abstract] [Full Text] [Related]
31. [Infection: causes, triggers and complications of rheumatic disease]. Märker-Hermann E; Schmidt RE Z Rheumatol; 2010 Dec; 69(10):863. PubMed ID: 21128046 [No Abstract] [Full Text] [Related]
32. [Immunosuppressive agents in rheumatoid polyarthritis. Introduction]. de Sèze S; Kahn MF Rev Rhum Mal Osteoartic; 1971 Dec; 38(12):737-9. PubMed ID: 5152705 [No Abstract] [Full Text] [Related]
33. [Symposium II. Immunosuppressive therapy in rheumatoid arthritis. 3. Pathologic effects of immunosuppressive agents and their adverse anti-inflammatory effects]. Kyogoku M; Watanabe S; Sagino H; Obu R; Shimomura R Ryumachi; 1973 Jan; 13(1):38-47. PubMed ID: 4726791 [No Abstract] [Full Text] [Related]
38. Treatment of rheumatoid arthritis with tacrolimus: tacrolimus-induced urticaria. Kamata Y; Iwamoto M; Minota S J Clin Rheumatol; 2009 Jun; 15(4):213. PubMed ID: 19502910 [No Abstract] [Full Text] [Related]
39. [Basic therapeutic and immunosuppressive drugs in rheumatoid arthritis. No fear of "heavy weapons"]. Krüger K MMW Fortschr Med; 2002 Aug; 144(33-34):25-30. PubMed ID: 12380140 [No Abstract] [Full Text] [Related]
40. [Therapy of rheumatoid arthritis with immunocytotoxic drugs]. Gigante D Minerva Med; 1973 Jun; 64(46):2412-7. PubMed ID: 4723569 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]